BUENOS AIRES--(BUSINESS WIRE)--GridX, Latin America's largest biotechnology investment fund and company builder, is set to begin its international Roadshow featuring 21 innovative startups across ...

As the world enters an age of biotechnology, there is emerging evidence that China is “distorting” biotechnology markets and is quickly ascending to “dominance” in this field, having made ...

One relatively small biotech company has made a breakthrough that could be used to treat a range of cancer. While it's been a poor performer for the past few years despite promising growth ...

A pioneer in Taiwan’s advanced manufacturing cell technologies, YJ Biotechnology has quickly established itself as one of the country’s leading names in the development of regenerative medicine.

As explained by Mr. Maick Su, CEO of NanoRay Biotech, AMT is a “first-in-human” combination therapy that applies IuDR, an iodinated analog of thymidine that can be used as a component of DNA ...

Passed by the House in September 2024, the Biosecure Act took a particularly hardline stance on Chinese biotech, denying top firms access to U.S. pharma supply chains. The bill forced U.S ...

Shanghai-based VelaVigo has been busy. The biotech granted Avenzo Therapeutics ex-China rights to a Nectin4xTROP2 bispecific antibody-drug conjugate in November, netting up to $50 million in ...

Mark Warner, D-Va., during discussions Wednesday. “In Roanoke, I think we’re one big deal away from the incredible biotech community that is nascent here kind of breaking through to the big ...

Mural Oncology is a biotechnology company that focuses on using its protein engineering platform to develop cytokine-based immunotherapies for cancer treatment. The company aims to deliver ...

We recently published a list of the 13 Best Biotech Penny Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Relay Therapeutics Inc. (NASDAQ:RLAY ...

We recently published a list of the 13 Best Biotech Penny Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Geron Corp. (NASDAQ:GERN) stands against ...

I often refer to Regeneron as a “Biotech Juggernaut” because it seems like they have similar strengths to the comic book character. The company appears to have unstoppable momentum thanks to a ...